Safety and Immunogenicity of the Live-Attenuated Hrvfv-4S Vaccine Against Rift Valley Fever in Healthy Adults: a Dose-Escalation, Placebo-Controlled, First-in-human, Phase 1 Randomised Clinical TrialIsabel Leroux-Roels,Chittappen Kandiyil Prajeeth,Amare Aregay, Niranjana Nair,Guus F Rimmelzwaan,Albert D M E Osterhaus, Simone Kardinahl, Sabrina Pelz, Stephan Bauer, Valentino D'Onofrio,Azhar Alhatemi,Bart Jacobs,Fien De Boever, Sharon Porrez,Gwenn Waerlop,Carine Punt, Bart Hendriks, Ellemieke von Mauw,Sandra van de Water,Jose Harders-WesterveenThe Lancet Infectious diseases（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
